Corbus Pharma (CRBP) Reports Q4 Loss of $0.28/Share

Corbus Pharma (NASDAQ: CRBP) reported Q4 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $648.4 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day